STOCK TITAN

Bruker (NASDAQ: BRKR) insider files to sell 2,000 shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Bruker Corporation insider Mark R. Munch has filed a Rule 144 notice to sell 2,000 shares of the company’s common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/15/2026 and an aggregate market value of $98,400. The securities were acquired on 01/15/2026 by exercising stock options granted by the issuer and were paid for in cash.

Over the prior three months, the same seller reported additional open-market sales of Bruker common stock. On 01/12/2026, 7,000 shares were sold for gross proceeds of $385,000, and on 01/05/2026, 33,843 shares were sold for gross proceeds of $1,680,704. The notice includes a representation that the seller does not know any material adverse, non-public information about Bruker’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What insider transaction does Bruker (BRKR) report in this Form 144?

The notice shows Mark R. Munch intends to sell 2,000 shares of Bruker common stock, acquired by stock option exercise and to be sold under Rule 144.

How and when were the 2,000 Bruker (BRKR) shares acquired?

The 2,000 common shares were acquired on 01/15/2026 through a stock option exercise from the issuer, with the exercise price paid in cash on the same date.

What are the planned sale terms for the new Bruker (BRKR) shares?

The Form 144 states the 2,000 common shares, with an aggregate market value of $98,400, are expected to be sold on or about 01/15/2026 on NASDAQ through Morgan Stanley Smith Barney LLC.

What Bruker (BRKR) shares has the insider sold in the last 3 months?

The filing lists two recent sales by Mark R. Munch: 7,000 shares on 01/12/2026 for $385,000 and 33,843 shares on 01/05/2026 for $1,680,704 in gross proceeds.

How many Bruker (BRKR) shares are outstanding in this Form 144?

The notice reports 151,941,144 Bruker common shares outstanding, which is provided as context for the 2,000-share planned sale.

What representation does the Bruker (BRKR) insider make in this notice?

By signing the notice, the seller represents that they do not know any material adverse information about Bruker’s current or prospective operations that has not been publicly disclosed.
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

7.52B
103.37M
31.98%
84.57%
5.51%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA